Yabao Pharmaceutical
Kunming, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A integrated Chinese pharma company with a focus on generic and branded small molecules.
Multiple (Small Molecules)
Technology Platform
Focuses on small molecule synthesis, formulation development, and scalable GMP manufacturing for generic and innovative drugs.
Opportunities
Growth through consolidation in the generics sector and development of differentiated, value-added formulations.
Risk Factors
Significant regulatory and pricing risks from China's ongoing healthcare reforms and centralized drug procurement schemes.
Competitive Landscape
Operates in the highly fragmented and competitive Chinese generic drug market, facing intense price competition.